We are live on
!
Find out more
HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
41.95%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$226M
(+10%)
Cap. Flow
+$94.9M
Cap. Flow
% of AUM
3.83%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
956
New
89
Increased
439
Reduced
377
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Preferred and Income Securities ETF
PFF
|
+$21.1M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$17.6M |
| 3 |
JEMB
Janus Henderson Emerging Markets Debt Hard Currency ETF
JEMB
|
+$6.97M |
| 4 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$5.64M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$5.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global X US Preferred ETF
PFFD
|
+$29.1M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$15M |
| 3 |
Insmed
INSM
|
+$2.72M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
+$2.36M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$1.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.64% |
| 2 | Financials | 10.39% |
| 3 | Healthcare | 9.29% |
| 4 | Industrials | 6.6% |
| 5 | Consumer Discretionary | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
901
Vistance Networks Inc
VISN
$2.66B
| $171K | 0.01% |
+20,700
| New | +$108K |
|
902
NOV
NOV
$7.4B
| $143K | 0.01% |
11,511
-134
| -1% | -$1.69K |
|
903
DHI Group
DHX
$167M
| $135K | 0.01% |
45,563
-5,790
| -11% | -$11.2K |
|
904
PagSeguro Digital
PAGS
$2.52B
| $131K | 0.01% |
+13,597
| New | +$123K |
|
905
Ironwood Pharmaceuticals
IRWD
$692M
| $124K | 0.01% |
172,579
-7,973
| -4% | -$6.26K |
|
906
Sally Beauty Holdings
SBH
$1.59B
| $122K | ﹤0.01% |
+13,125
| New | +$113K |
|
907
Pliant Therapeutics
PLRX
$65M
| $116K | ﹤0.01% |
99,819
-4,611
| -4% | -$6.51K |
|
908
KRONOS Worldwide
KRO
$1B
| $110K | ﹤0.01% |
+17,676
| New | +$121K |
|
909
Superior Group of Companies
SGC
$205M
| $109K | ﹤0.01% |
10,544
-152
| -1% | -$1.55K |
|
910
Repay Holdings
RPAY
$306M
| $94.9K | ﹤0.01% |
19,681
-334
| -2% | -$1.52K |
|
911
1-800-Flowers.com
FLWS
$256M
| $92.2K | ﹤0.01% |
18,737
-4
| -0% | -$21 |
|
|
APLT
912
DELISTED
Applied Therapeutics
APLT
| $89.6K | ﹤0.01% |
287,998
-13,305
| -4% | -$5.15K |
|
913
ZipRecruiter
ZIP
$409M
| $56.5K | ﹤0.01% |
11,282
-837
| -7% | -$4.57K |
|
|
VMEO
914
DELISTED
Vimeo
VMEO
| $53.9K | ﹤0.01% |
+13,331
| New | +$61.7K |
|
|
BRFS
915
DELISTED
BRF SA
BRFS
| $43K | ﹤0.01% |
11,792
+27
| +0.2% | +$98 |
|
|
SBDS
916
DELISTED
Solo Brands Inc
SBDS
| $32.1K | ﹤0.01% |
2,676
-113
| -4% | -$638 |
|
917
ACI Worldwide
ACIW
$5.27B
| – | – |
-6,942
| Closed | -$380K |
|
|
AGEN
918
Agenus
AGEN
$296M
| – | – |
-23,892
| Closed | -$36K |
|
919
Aldeyra Therapeutics
ALDX
$91.1M
| – | – |
-69,442
| Closed | -$399K |
|
920
Amphastar Pharmaceuticals
AMPH
$864M
| – | – |
-7,764
| Closed | -$225K |
|
921
Biogen
BIIB
$30.6B
| – | – |
-1,891
| Closed | -$259K |
|
922
Brady Corp
BRC
$4.52B
| – | – |
-4,518
| Closed | -$319K |
|
923
Carrier Global
CARR
$53.1B
| – | – |
-3,340
| Closed | -$212K |
|
924
Capitol Federal Financial
CFFN
$1.09B
| – | – |
-11,425
| Closed | -$64K |
|
925
Crinetics Pharmaceuticals
CRNX
$8.94B
| – | – |
-32,580
| Closed | -$1.09M |
|
Similar funds
TCM
BCP
TH
DILIC
TYCC
ACM
MSC
DAM
Hennion & Walsh Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Hennion & Walsh Asset Management held 956 positions worth $2.48B, up 10% from $2.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Hennion & Walsh Asset Management deployed $94.9M of net new capital in Q2 2025, opening 89 new positions and adding to 439 existing holdings. Its largest new stake was iShares Preferred and Income Securities ETF: 700,414 shares worth $21.5M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Global X US Preferred ETF, an estimated $29.1M trimmed.
- Hennion & Walsh Asset Management's largest Q2 2025 buy was iShares Preferred and Income Securities ETF: 700,414 shares worth $21.5M.
- Hennion & Walsh Asset Management added most to iShares International Select Dividend ETF in Q2 2025, an estimated $5.17M increase.
- Hennion & Walsh Asset Management's biggest Q2 2025 reduction was Global X US Preferred ETF, cutting an estimated $29.1M.
- Hennion & Walsh Asset Management fully exited Insmed in Q2 2025, selling an estimated $2.72M.
- Hennion & Walsh Asset Management's ten largest holdings make up 19% of its $2.48B portfolio in Q2 2025.
- Hennion & Walsh Asset Management opened 89 new positions and closed 40 in Q2 2025.
- Hennion & Walsh Asset Management's portfolio value rose 10% quarter-over-quarter to $2.48B.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.